Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Organization and analysis of safety data using a multivariate approach.

C Chuang-Stein1, N R Mohberg, D M Musselman

  • 1Research Support Biostatistics, Upjohn Company, Kalamazoo, MI 49001.

Statistics in Medicine
|June 15, 1992
PubMed
Summary

This study introduces a new method for organizing clinical trial safety data into body system classes. This approach enhances the power of statistical comparisons between treatment safety profiles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selection bias for treatments with positive Phase 2 results.

Pharmaceutical statistics·2020
Same author

Recent Developments in the Prevention and Treatment of Missing Data.

Therapeutic innovation & regulatory science·2018
Same author

Discounting phase 2 results when planning phase 3 clinical trials.

Pharmaceutical statistics·2012
Same author

A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.

BJU international·2003
Same author

Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.

Journal of biopharmaceutical statistics·2002
Same author

Laboratory data in clinical trials: a statistician's perspective.

Controlled clinical trials·1998

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacovigilance

Background:

  • Clinical trials generate extensive safety data, often leading to unfocused statistical comparisons.
  • Current methods for analyzing safety profiles can lack power and yield inconclusive results.
  • Organizing safety data is crucial for effective clinical trial analysis.

Purpose of the Study:

  • To propose a structured method for organizing and analyzing clinical trial safety data.
  • To enhance the statistical power of safety profile comparisons between different treatments.
  • To provide a more focused and informative approach to safety data evaluation.

Main Methods:

  • Consolidating safety data into K classes based on body systems, disease, and treatments.
  • Assigning an overall intensity grade to each patient within each class.

Related Experiment Videos

  • Utilizing multivariate comparison of mean intensity grades with acceptability scores.

    • Main Results:

    • The proposed data organization provides an informative summary of treatment safety profiles.
    • Multivariate comparison demonstrates significantly higher power than univariate methods in detecting differences.
    • The method offers a more focused and structured approach to safety data analysis.

    Conclusions:

    • Organizing safety data into body system classes improves the analysis of treatment safety profiles.
    • The proposed multivariate comparison method is more powerful for detecting safety differences.
    • This approach offers a structured and efficient way to manage and interpret clinical trial safety data.